surface antigen and cell membrane penetration, it converts its viral RNA into proviral DNA by means of an enzyme it carries, termed reverse transcriptuse. The proviral DNA then becomes incorporated into the host cell's own DNA. By incorporating itself into the host's DNA, the infection continues throughout the lifetime of the host cell. All progeny of infected cells will carry viral genes. Viral DNA may not only express itself by causing disease-both neoplastic and non-neoplasticbut may also affect neighbor host DNA enough to cause disease expre~sion.~ By disrupting OKT4 helper lymphocytes, the infection prevents maturation of cytotoxic T-cells, a major function of OKT4 cells. This markedly affects the immunologic capabilities of the host organism. ' Several other immunologic abnormalities are seen in patients with AIDS. Lymphopenia secondary to loss of OKT4 cells is common. An early screening test for AIDS-used when the nature of the disease was first appreciated-was the T4/T8 ratio (helper/suppressor ratio), which often decreased to the point of reversal because of a markedly reduced numerator. Functional T-cell defects include decreased blast cell transformation in response to mitogens and antigens, decreased lymphokine production, decreased alloreactivity, decreased cytotoxic cell response, and decreased helper function for B-cell immunoglobulin production. B lymphocytes are also affected by this disease. 6 Polyclonal B lymphocyte activation has been described in AIDS research. This activation-with immunoglobulin secretion-is not a response to signals that normally trigger B cells to produce a specific an-Otdaryngology-Head and Neck Surgery tibody to an infective antigen. Rather, it is a diffuse outpouring of immunoglobulins that prevents normal humoral effective immune responses. Monocytes also develop functional defects. Monocytes are placed in a preactivated state that results in diminished monocyte responsiveness to de-novo antigen. Also encountered is an increase in p-2 macroglobulin and ~-1-thymosin.~
The incubation period is still believed to be prolonged, ranging from 16 to 65 months in one series (average 38 months). A syndrome with symptoms similar to infectious mononucleosis may be apparent during the first few weeks following infection. Approximately 4 to 5 weeks after inoculation, a rise in IgG levels (and occasionally IgM levels) may be seen.' Virtually all patients with AIDS develop an antibody to HTLV-111. Patients with very severe disease may lose their detectable HTLV-111 antibody as a terminal event.'
Detection of the HTLV-111 antibody (seropositivity) has become an important test for screening patients and human by-products exposed to the virus. This test involves an enzyme-linked immunosorbent assay (ELISA). It does have a high false-positive rate and is usually repeated for confirmation. A second confirmation test often performed, termed the Western blot, uses electrophoretically banded proteins that characterize-by molecular size-those bands typically associated with the virus (viral core antigen or envelope antigen).'
Risk factors for seropositivity depend on the risk group involved. The four major risk groups are homosexuals, intravenous drug abusers, hemophiliacs, and blood transfusion recipients. Among homosexuals, large numbers of sexual encounters (especially more than 10 per year) and the engagement in anal intercourse increase one's risk for seropositivity. Among persons with hemophilia, risk increases with the degree of disease-and, therefore, the number of transfusions of factor VIII required. The same applies to blood product recipients with regard to the number of transfusions received. '
HTLV-I11 infection is believed to first cause an antibody-negative (healthy) carrier state followed by seroconversion. Subclinical or clinical disease then follows in a percentage of those infected.' While the exact percentage is not known, it is believed to be between 5% and 33%. The clinical findings are well described in the past literature and have not changed substantially. Pneumocystis carinii pneumonia remains the most common pathologic process (43%), followed in incidence by Kaposi's sarcoma (on the decline from 21% pre-1985 to approximately 13% today).* Recent findings have suggested a direct relation between HTLV-111 and some neurologic syndromes, in-cluding chronic meningitis, dementia, and so-called AIDS encephalopathy, that occur in patients with AIDS and AIDS-related complex (ARC-often a prodrome of AIDS). HTLV-111 may be not only lymphotropic, but neurotropic as well. The brain may provide a sanctuary for HTLV-111 virus and a reservoir for replication. The blood-brain barrier may, therefore, make future treatments more diffic~lt.'.'~ The major effort in research of this disease is an attempt to find a cure for the disease process itself and not simply the opportunistic diseases that have become associated with it. There are several sites of possible intervention, and drugs are now being studied for efficacy at each site. Agents that block viral particles from adsorbing to cell surfaces and penetrating include specific monoclonal antibodies. Reverse transcriptase inhibitors are being investigated-these include template/ primer-binding compounds (e.g. distamycin A), enzyme-binding compounds (e.g. ansamycin), template analogs, chelating agents (e.g. isoniazid), substrate analogs (e.g. ribavirin), pyrophosphate analogs (e.g. trisodium phosphonoformate), and polyanionic substances that compete with template primer (e.g. suramin). Finally, agents that affect post-transcriptional processing, protein assembly, and release-such as Vidarabine, Deoxyadenosine, and protease inhibitorsare being tested. It is hoped that a combination of antiviral agents and immunomodulators (such as interleukin-2 and thymic humoral factors) will provide a cure for this illness."
Of special concern is the involvement of infants and children with AIDS, of which there are now 231 reported cases.2 The disease process itself is the same as in adults, but, because of the relatively pristine immunologic status of newborns and infants, several tests are altered and several other opportunistic diseases are seen. Delayed hypersensitivity skin tests are of little value in evaluation of cell-mediated immunity because such patients lack exposure to antigen. Kaposi's sarcoma is highly unusual in these patients, but chronic parotid swelling and lymphoid interstitial pneumonia are common. Clinical features of AIDS should not be a prerequisite for the diagnosis of pediatric AIDS, as these are late manifestations of the syndrome and may delay appropriate treatment. Classification of pediatric AIDS is made on analysis of four areas: (1) epidemiology (history of risk factors); (2) immunology (polyclonal hypergammaglobulinemia and T-cell immunodeficiency); (3) virology (antibody to AIDS retrovirus or viral isolation); and (4) exclusion of other immunologic disorders (primary immunodeficiency, adenosine deaminase deficiency, and nucleoside phosphorylase deficiency).
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Finally, as otolaryngologists, we will be called upon to evaluate patients with AIDS. There is obvious concern in the health care profession about exposure and possible infection. In a recent examination of 1758 health care workers who cared for AIDS patients, 26 (1.5%) were found seropositive for HTLV-111 antibody. All but three of these belonged to groups recognized to be at increased risk for AIDS; it is believed that these three workers were infected by needle-stick accidents. l 3 Another report in the English literature described a nurse who developed HTLV-111 antibody after needlestick injury.I4 It was deduced by these studies that the risk of transmission to health care workers is extremely low. It is less transmissible through needle-sticks than is hepatitis B. Precautions for health care workers are similar to those taken for hepatitis B. With proper caution, the diagnosis of AIDS should in no way prevent a patient from receiving proper medical care. I' Acquired immunodeficiency disease will remain an illness of intense medical study for some time to come. Inroads are being made into its recognition and treatment. Cooperation among many groups for a prolonged period will be required for understanding and control of this disease.
Edltor'r note-
This month's editorial "Update on Aids" was invited from Doctors Rosenberg, Schneider and Cohen to follow-up on the call by Doctor R. Nevin Rupp for a benchmark dissertation on this subject for otolaryngologists (see correspondence in Letters to the Editor). Doctor Rupp was given the opportunity to review this submission and add some important perspectives, which follow here.
To the Editor:
I very much appreciate the opportunity of reviewing the article "Update on AIDS" by Rosenberg, Schneider, and Cohen. It is a very excellent technical article and clearly contains up-to-date statistical data, as well as much of the recently acquired knowledge of the physiology of the organism and the pathophysiology of the disease. Unfortunately, there is little in the article that would be of much help to the practicing otolaryngologist in his management of this increasingly common problem.
I was glad to see that this article did not perpetuate the fear (that many in the health care fields have had) of acquiring the disease in the care of their patients. The authors mentioned the three described in his reference from the Center of Disease Control, MMWR. However, one must have significant doubt that these were, in fact, from a high-risk group. My experience, though, is certainly skewed in this area, as the first patient I cared for with this disease was a fellow otolaryngologist who carried the secret of his active homosexuality to the grave. It was only after his death that there was irrefutable evidence of his active homosexual life.
Nonetheless, I think all otolaryngologists should be a little more careful and handle every patient in such a manner that the examiner not be contaminated with blood or saliva. Though it may be somewhat difficult to acquire AIDS from normal contact with patients, our knowledge in this field is still far from solid. Our knowledge of contracting hepatitis in this manner is well-documented and should stimulate use of regular precautions. In my practice, the only way I have exceeded these precautions is that I do wear gloves when caring for a patient who has given me some reason to suspect he or she may be in a high-risk group for AIDS.
Every otolaryngologist must be alert to the manifestations of this disease, as many of the patients with AIDS will make him their first contact. In my personal experience, I have come to be highly suspicious of a patient with any infection in any area due to unusual organisms that seems to get well but recurs relentlessly. If in such a patient there is a leukopenia-especially a lymphopenia-the index of suspicion should be very high. We will also see as presenting symptoms unexplained lymphadenopathy, including cervical, axillary, and inguinal. Recurrent aphthous stomatitis is common in an otolaryngologist's practice; however, more severe herpes simplex stomatopharyngitis-which does not behave in the way that the usual aphthous stomatitis does or which is new for the patient-should create suspicion. Monoliasis in the mouth is not uncommon in our patients with extensive antibiotic therapy. However, if it extends to the pharynx, trachea, and esophagus, it should generate strong suspicion of AIDS. The presence of unusual purplish patches in the mouth (which on biopsy prove to be Kaposi's sarcoma) is almost diagnostic. Unexplained weight loss and fever of undetermined originespecially associated with night sweats-occur in a high percentage of patients with early AIDS. If a cough develops, it could be due to Pneumocystis carinii pneumonia. In this disease, the chest may sound absolutely clear, though the x-ray film is characteristic of interstitial pneumonia. Diagnosis, of course, must be made by bronchial biopsy. Sputum alone will not usually show it. This is diagnostic of AIDS.
Most of the patients we see will still be in the AIDS-related complex stage of the disease. They will not, as yet, have acquired one of the opportunistic infections required by the CDC for diagnosis. Nonetheless, when any of the previously mentioned problems are seen in a patient, I always order antibody studies for the HTLV-I11 virus. This consists first of the ELISA and, if positive, a Western Blot should be performed. If this very sensitive test is positive, the patient has the specific antibodies and-combined with clinical findings-has either the AIDS-related complex or the full-blown disease. One must not hesitate to order these readily available tests, and they can be done as discreetly as any serologic tests for syphilis that we might order for other problems.
Again, I appreciate an opportunity to read the article on updating of AIDS information and to offer my thoughts.
R . Nevin Rupp, MD

